BRPI0519890A2 - macrociclos de 18 elementos e seus análogos - Google Patents
macrociclos de 18 elementos e seus análogosInfo
- Publication number
- BRPI0519890A2 BRPI0519890A2 BRPI0519890-9A BRPI0519890A BRPI0519890A2 BR PI0519890 A2 BRPI0519890 A2 BR PI0519890A2 BR PI0519890 A BRPI0519890 A BR PI0519890A BR PI0519890 A2 BRPI0519890 A2 BR PI0519890A2
- Authority
- BR
- Brazil
- Prior art keywords
- opt
- macrocycles
- thiacumycin
- analogues
- specifically
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2005/002887 WO2006085838A1 (en) | 2005-01-31 | 2005-01-31 | 18-membered macrocycles and analogs thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0519890A2 true BRPI0519890A2 (pt) | 2009-03-31 |
Family
ID=36793325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0519890-9A BRPI0519890A2 (pt) | 2005-01-31 | 2005-01-31 | macrociclos de 18 elementos e seus análogos |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1848273A4 (ja) |
| JP (1) | JP5166040B2 (ja) |
| KR (1) | KR101203118B1 (ja) |
| CN (2) | CN102614207B (ja) |
| AU (1) | AU2005327308B2 (ja) |
| BR (1) | BRPI0519890A2 (ja) |
| CA (1) | CA2596387C (ja) |
| MX (2) | MX2007009196A (ja) |
| TW (1) | TWI306097B (ja) |
| WO (1) | WO2006085838A1 (ja) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7906489B2 (en) | 2004-05-14 | 2011-03-15 | Optimer Pharmaceuticals, Inc. | 18-membered macrocycles and analogs thereof |
| US7378508B2 (en) * | 2007-01-22 | 2008-05-27 | Optimer Pharmaceuticals, Inc. | Polymorphic crystalline forms of tiacumicin B |
| AU2006304868B2 (en) * | 2005-10-21 | 2013-02-21 | Merck Sharp & Dohme Corp. | Method of treating clostridium difficile-associated diarrhea |
| TWI482772B (zh) * | 2006-08-21 | 2015-05-01 | Astrazeneca Ab | 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物 |
| US20080176927A1 (en) | 2007-01-19 | 2008-07-24 | Optimer Pharmaceuticals, Inc. | Compositions of stable tiacumicins |
| AU2012244278C1 (en) * | 2007-01-22 | 2014-11-06 | Merck Sharp & Dohme Llc | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |
| ZA200905337B (en) * | 2007-01-22 | 2010-10-27 | Optimer Pharmaceuticals Inc | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |
| TWI523654B (zh) * | 2007-11-27 | 2016-03-01 | 默沙東藥廠 | 抗生素巨環化合物以及其製造及使用之方法 |
| CA2826662A1 (en) * | 2011-02-04 | 2012-08-09 | Optimer Pharmaceuticals, Inc. | Treatment of bacterial infections |
| EP2855499A1 (en) * | 2012-05-10 | 2015-04-08 | Teva Pharmaceutical Works Ltd. | Solid state forms of fidaxomycin and processes for preparation thereof |
| US8722863B2 (en) | 2012-05-10 | 2014-05-13 | Teva Pharmaceutical Works Ltd. | Solid state forms of fidaxomycin and processes for preparation thereof |
| JO3464B1 (ar) | 2013-01-15 | 2020-07-05 | Astellas Pharma Europe Ltd | التركيبات الخاصة بمركبات التياكوميسين |
| CN103275152B (zh) * | 2013-05-29 | 2015-11-18 | 华北制药集团新药研究开发有限责任公司 | 一种高纯度非达霉素的制备方法 |
| KR20160134719A (ko) * | 2014-03-18 | 2016-11-23 | 셀리아 파마슈티칼즈 에이피에스 | 신규한 다형체 및 신규한 고체 상태의 티아쿠미신 ｂ |
| CN103897003B (zh) * | 2014-03-28 | 2016-07-06 | 华北制药集团新药研究开发有限责任公司 | 非达霉素晶型ii及其制备方法 |
| US10137141B2 (en) | 2014-05-09 | 2018-11-27 | Astellas Pharma Europe Ltd. | Treatment regimen tiacumicin compound |
| US10548912B2 (en) | 2015-07-03 | 2020-02-04 | Astellas Pharma Europe Ltd. | Dosage regimen for a tiacumicin compound |
| CN105237599B (zh) * | 2015-10-09 | 2018-10-02 | 华北制药集团新药研究开发有限责任公司 | 闰年霉素a4晶体及其制备方法 |
| CN110183502A (zh) * | 2019-05-28 | 2019-08-30 | 杭州华东医药集团新药研究院有限公司 | 一种非达霉素杂质及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1458512A (en) * | 1973-11-22 | 1976-12-15 | Lepetit Spa | Antibiotic substance |
| US4918174A (en) * | 1986-09-26 | 1990-04-17 | Abbott Laboratories | Tiacumicin compounds |
| US5583115A (en) * | 1995-05-09 | 1996-12-10 | Abbott Laboratories | Dialkyltiacumicin compounds |
| US5767096A (en) * | 1996-07-12 | 1998-06-16 | Abbott Laboratories | Bromotiacumicin compounds |
| JP2005534332A (ja) * | 2002-07-29 | 2005-11-17 | オプティマー ファーマシューティカルズ、インコーポレイテッド | チアクマイシン生産 |
| PL2070530T3 (pl) * | 2004-05-14 | 2016-06-30 | Merck Sharp & Dohme | Leczenie chorób związanych ze stosowaniem antybiotyków |
-
2005
- 2005-01-31 JP JP2007553073A patent/JP5166040B2/ja active Active
- 2005-01-31 KR KR1020077019982A patent/KR101203118B1/ko active IP Right Grant
- 2005-01-31 CN CN201210032395.4A patent/CN102614207B/zh active Active
- 2005-01-31 EP EP05712354A patent/EP1848273A4/en not_active Ceased
- 2005-01-31 MX MX2007009196A patent/MX2007009196A/es active IP Right Grant
- 2005-01-31 CA CA2596387A patent/CA2596387C/en active Active
- 2005-01-31 CN CN2005800487153A patent/CN101128114B/zh active Active
- 2005-01-31 AU AU2005327308A patent/AU2005327308B2/en active Active
- 2005-01-31 MX MX2012009525A patent/MX340742B/es unknown
- 2005-01-31 BR BRPI0519890-9A patent/BRPI0519890A2/pt not_active Application Discontinuation
- 2005-01-31 WO PCT/US2005/002887 patent/WO2006085838A1/en active Application Filing
- 2005-05-17 TW TW094115942A patent/TWI306097B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070110504A (ko) | 2007-11-19 |
| WO2006085838A1 (en) | 2006-08-17 |
| CA2596387C (en) | 2012-11-20 |
| AU2005327308B2 (en) | 2011-11-10 |
| AU2005327308A1 (en) | 2006-08-17 |
| MX340742B (es) | 2016-07-21 |
| TWI306097B (en) | 2009-02-11 |
| CA2596387A1 (en) | 2006-08-17 |
| CN102614207B (zh) | 2016-01-13 |
| JP2008528582A (ja) | 2008-07-31 |
| CN101128114B (zh) | 2012-03-28 |
| KR101203118B1 (ko) | 2012-11-20 |
| JP5166040B2 (ja) | 2013-03-21 |
| TW200626585A (en) | 2006-08-01 |
| EP1848273A4 (en) | 2010-02-24 |
| MX2007009196A (es) | 2009-02-25 |
| CN102614207A (zh) | 2012-08-01 |
| EP1848273A1 (en) | 2007-10-31 |
| CN101128114A (zh) | 2008-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0519890A2 (pt) | macrociclos de 18 elementos e seus análogos | |
| PH12018550173A1 (en) | Pyrazolopyrimidine derivatives | |
| CL2007001427A1 (es) | Sal de maleato de 5-amino-3-(2',3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d]pirimidin-2-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una infeccion po | |
| BRPI0809977A8 (pt) | Uso de um composto, compostos e composição farmacêutica que o contém | |
| AR053162A1 (es) | Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma. | |
| BR122014013631B8 (pt) | compostos antivirais, seu uso e composição farmacêutica compreendendo os mesmos | |
| BRPI0619153A8 (pt) | derivados de 4-aminopirroltriazina substituída, e composição farmacêutica | |
| EA200802390A1 (ru) | Конъюгаты аналогов азиридилэпотилона и фармацевтические композиции, содержащие их | |
| NI201200044A (es) | Compuestos de dióxido de iminotiadiazina como inhibodores de bace , composiciones y su uso | |
| HN2012001162A (es) | Triazolopiridinas | |
| BR112014006297A2 (pt) | inibidores de n-[1-ciano-2-(fenil) etil]-2-azabiciclo [2.2.1] heptano-3-carboxamida de catepsina c, seus usos, e composição farmacêutica | |
| UA96964C2 (ru) | Соединения полициклической мочевины с антибактериальными свойствами | |
| GT200600161A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
| BR112013028666A2 (pt) | compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo | |
| GT200900154A (es) | Derivados de 2,3-dihidroimidozo [1,2-c] quinizolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis | |
| CL2008000959A1 (es) | Compuestos derivados de 1,2,4-tiadiazina o 1,4-tiazina; composiciones farmaceuticas que los contienen; y su uso para la prevencion y/o tratamiento de infecciones producidas por el virus de la hepatitis c. | |
| AR054347A1 (es) | Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| BRPI0407306A (pt) | 1,2,4- triazinas de inibição de hiv | |
| ME01456B (me) | Fumaratna so (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola | |
| BRPI0821855B8 (pt) | composto, composição farmacêutica, e, uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
| CO2020001242A2 (es) | Dihidrooxadiazinonas | |
| GT200800187A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
| BRPI0706992C1 (pt) | composto de fórmula (i) e formulação farmacêutica | |
| BR112015026840A2 (pt) | composto, sal farmaceuticamente aceitável, composição farmacêutica, uso de um composto, e, método prevenir ou tratar hiperfosfatemia | |
| BR112012013252A2 (pt) | composição farmacêutica tópica, preservativo, composto, e, uso do mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: OPTIMER PHARMACEUTICALS LLC (US) |
|
| B25A | Requested transfer of rights approved |
Owner name: MERCK SHARP AND DOHME CORP (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |